menu
    • menu

    Company profile for Inovio Pharmaceuticals

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Inovio's technology platform is capable of activating antigen-specific immune responses. Aptly named ASPIRE™ (Antigen SPecific Immune REsponses), this unique technology is primed to change the way cancer and infectious disease are treated. With demonstrated efficacy in a Phase 2b trial, robust and targeted immune responses, a favorable safety profile, and a robust pipeline of product candidates across multiple disease states...
    Inovio's technology platform is capable of activating antigen-specific immune responses. Aptly named ASPIRE™ (Antigen SPecific Immune REsponses), this unique technology is primed to change the way cancer and infectious disease are treated. With demonstrated efficacy in a Phase 2b trial, robust and targeted immune responses, a favorable safety profile, and a robust pipeline of product candidates across multiple disease states, the evidence to date is clear—ASPIRE is realizing the true promise of immunotherapy.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Inovio PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    660 W. Germantown Pike, Suite 110 Plymouth Meeting, PA 19462
    Telephone
    Telephone
    267-440-4200
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.inovio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    FDA Reviews Inovio's BLA For INO-3107 In Adult (RRP) Treatment
    FDA Reviews Inovio's BLA For INO-3107 In Adult (RRP) Treatment

    29 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/fda-accepts-for-review-inovios-bla-for-ino-3107-for-the-treatment-of-adults-with-recurrent-respiratory-papillomatosis-rrp-302649910.html

    PR NEWSWIRE
    29 Dec 2025
    Share Share
    INOVIO Reports Inducement Grant Under Inducement Plan
    INOVIO Reports Inducement Grant Under Inducement Plan

    20 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/inovio-reports-inducement-grant-under-inducement-plan-302647275.html

    PR NEWSWIRE
    20 Dec 2025
    Share Share
    INOVIO To Participate In December Investor Conferences
    INOVIO To Participate In December Investor Conferences

    18 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/inovio-to-participate-in-december-investor-conferences-302618252.html

    PR NEWSWIRE
    18 Nov 2025
    Share Share
    INOVIO Announces Proposed Public Offering
    INOVIO Announces Proposed Public Offering

    11 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/inovio-announces-proposed-public-offering-302610778.html

    PR NEWSWIRE
    11 Nov 2025
    Share Share
    INOVIO Announces Pricing Of $25 Million Public Offering
    INOVIO Announces Pricing Of $25 Million Public Offering

    11 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/inovio-announces-pricing-of-25-million-public-offering-302611604.html

    PR NEWSWIRE
    11 Nov 2025
    Share Share
    INOVIO Reveals Q3 2025 Financials & Business Updates
    INOVIO Reveals Q3 2025 Financials & Business Updates

    10 Nov 2025

    // PR NEWSWIRE BIO

    https://www.prnewswire.com/news-releases/inovio-reports-third-quarter-2025-financial-results-and-recent-business-highlights-302610540.html

    PR NEWSWIRE BIO
    10 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search